Amundi
CYTK icon

Amundi’s Cytokinetics CYTK Stock Holding History

Amundi’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.13M Buy
17,078
+10,305
+152% +$655K ﹤0.01% 1248
2025
Q4 		$430K Buy
+6,773
New +$421K ﹤0.01% 1531
2025
Q2 		– Sell
-54
Closed -$2.19K – 1794
2025
Q1 		$2.19K Buy
54
+1
+2% +$46 ﹤0.01% 1955
2024
Q4 		$2.51K Buy
+53
New +$2.75K ﹤0.01% 1977
2024
Q1 		– Sell
-13,168
Closed -$1.34M – 2013
2023
Q4 		$1.34M Buy
13,168
+1,140
+9% +$41.3K ﹤0.01% 1282
2023
Q3 		$411K Sell
12,028
-243
-2% -$8.09K ﹤0.01% 1441
2023
Q2 		$409K Sell
12,271
-701
-5% -$25.9K ﹤0.01% 1429
2023
Q1 		$469K Buy
+12,972
New +$529K ﹤0.01% 1375

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return